[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU6384099A - Blended compositions for treatment of alzheimer's disease and other amyloidoses - Google Patents

Blended compositions for treatment of alzheimer's disease and other amyloidoses

Info

Publication number
AU6384099A
AU6384099A AU63840/99A AU6384099A AU6384099A AU 6384099 A AU6384099 A AU 6384099A AU 63840/99 A AU63840/99 A AU 63840/99A AU 6384099 A AU6384099 A AU 6384099A AU 6384099 A AU6384099 A AU 6384099A
Authority
AU
Australia
Prior art keywords
amyloidoses
alzheimer
disease
treatment
blended compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63840/99A
Inventor
Gerardo Castillo
Alan D. Snow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ProteoTech Inc
Original Assignee
ProteoTech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ProteoTech Inc filed Critical ProteoTech Inc
Publication of AU6384099A publication Critical patent/AU6384099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU63840/99A 1998-08-31 1999-08-30 Blended compositions for treatment of alzheimer's disease and other amyloidoses Abandoned AU6384099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9847398P 1998-08-31 1998-08-31
US60098473 1998-08-31
PCT/US1999/019721 WO2000012102A1 (en) 1998-08-31 1999-08-30 Blended compositions for treatment of alzheimer's disease and other amyloidoses

Publications (1)

Publication Number Publication Date
AU6384099A true AU6384099A (en) 2000-03-21

Family

ID=22269432

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63840/99A Abandoned AU6384099A (en) 1998-08-31 1999-08-30 Blended compositions for treatment of alzheimer's disease and other amyloidoses

Country Status (2)

Country Link
AU (1) AU6384099A (en)
WO (1) WO2000012102A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU783688B2 (en) * 1999-09-06 2005-11-24 Good Health Products Limited Improvements in or relating to consumable health products
US20020068729A1 (en) 2000-07-13 2002-06-06 Alteon, Inc. Method for treating fibrotic diseases or other indications IC
DE10043282A1 (en) * 2000-09-02 2002-03-28 Kurt Heininger Medicaments containing amyloid-beta-protein formation and/or secretion inhibitors, are used for treating hypertension, diabetes, arteriosclerosis, rheumatism, cardiac infarction, inflammation or sepsis
US20070208087A1 (en) 2001-11-02 2007-09-06 Sanders Virginia J Compounds, compositions and methods for the treatment of inflammatory diseases
US20040260076A1 (en) 2002-10-11 2004-12-23 Castillo Gerardo M. Isolation, purification and synthesis of procyanidin B2 and uses thereof
JP2004043443A (en) * 2002-05-14 2004-02-12 Kumamoto Technology & Industry Foundation Preventive and therapeutic medicine of amyloidosis
CN100457122C (en) * 2002-05-14 2009-02-04 尼普洛株式会社 Medicine for prevention of and treatment for amyloidosis
WO2003101927A1 (en) 2002-05-31 2003-12-11 Proteotech, Inc. Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
JPWO2006054757A1 (en) * 2004-11-16 2008-06-05 アステラス製薬株式会社 Caspase inhibitor
NZ563660A (en) 2005-05-23 2012-11-30 Massachusetts Inst Technology Compositions containing PUFA and/or uridine and methods of use thereof
US8871715B2 (en) 2005-10-14 2014-10-28 Alltech, Inc. Use of selenium compounds, especially selenium yeasts for altering cognitive function
CN102764279B (en) * 2005-10-14 2015-04-01 全面技术公司 Method and composition for modifying cyte functions
AU2013205053B2 (en) * 2005-10-14 2015-07-23 Alltech, Inc. Method and compositions for altering cell function
US8865763B2 (en) 2005-10-14 2014-10-21 Alltech, Inc. Methods and compositions for altering cell function
US20150065449A1 (en) 2011-08-12 2015-03-05 Florida State University Research Foundation, Inc. Treating Amyloidoses With A Vitamin B12 Composition Including Melatonin, Resveratrol, and EGCG
CN104082659B (en) * 2014-06-13 2016-10-05 南京林业大学 Strengthen composition and the application thereof of memory
CN105687582A (en) * 2016-03-23 2016-06-22 中国药科大学 Chinese medicinal composition for preventing and treating senile dementia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302611A (en) * 1980-10-07 1994-04-12 Klaus Keplinger Oxindole alkaloids having properties stimulating the immunologic system & preparation containing the same
US5464619A (en) * 1994-06-03 1995-11-07 The Procter & Gamble Company Beverage compositions containing green tea solids, electrolytes and carbohydrates to provide improved cellular hydration and drinkability
US5571441A (en) * 1994-11-01 1996-11-05 The Procter & Gamble Company Nutrient supplement compositions providing physiologic feedback

Also Published As

Publication number Publication date
WO2000012102A1 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
AU3113500A (en) Compositions for treating alzheimer's disease and other amyloidoses
AU6384099A (en) Blended compositions for treatment of alzheimer's disease and other amyloidoses
AU2001249835A1 (en) Diagnosis and treatment of alzheimer's disease
AU2002219824A1 (en) Compositions and methods for diagnosing alzheimer's disease
HUP0103654A2 (en) Use of smilagenin and anzurogenin-d for production of pharmaceutical compositions for the treatment of alzheimer's disease
AU6905391A (en) Methods and compositions for the treatment of hodgkin's disease
AU1407399A (en) Treatment for alzheimer's disease
HUP0103255A3 (en) Compositions and methods for treatment of mitochondrial diseases
HUP0100737A3 (en) Use of phytosterol for preventing and delaying the onset of alzheimer's disease and phytosterol containing pharmaceutical compositions
AU2124397A (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
EP1105113A4 (en) Composition and method for treating peyronie's disease and other sub-dermal plaque manifestation disorders
AU7397094A (en) Prevention and treatment of alzheimer's disease
EP1129217A4 (en) Compositions and methods of disease diagnosis and therapy
AU2002239765A1 (en) Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease
AU3173301A (en) Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity
AU1734895A (en) Methods and compositions for treatment of periodontal disease and repair of periodontal lesions
AU3364499A (en) Method for delaying the onset of alzheimer's disease and for treating or delaying the onset of other amyloidosis-related diseases/disorders
AU3886200A (en) Methods of treating alzheimer's disease and other amyloidoses using hypericum perforatum and derivatives thereof
AU2002222108A1 (en) Diagnosis and treatment of alzheimer's disease
AU2001257406A1 (en) Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
AU1831195A (en) Methods and compositions for treatment and diagnosis of alzheimer disease and other disorders
AU5550800A (en) Diagnosis and treatment of alzheimer's disease
AU1405899A (en) Treatment for alzheimer's disease
AU5293293A (en) Methods and compositions for treatment of allergic disease
HUP0103149A3 (en) Pharmaceutical composition for treatment of alzheimer's disease

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase